Skip to main content
Premium Trial:

Request an Annual Quote

Germany's Altona Diagnostics Opens Malaysian Outpost

Premium

Altona Diagnostics last week opened the doors of ADT Biotech, the company's new Asia-Pacific regional headquarters in Kuala Lumpur, Malaysia.

Altona, based in Hamburg, Germany, develops and commercializes molecular diagnostic kits based on real-time PCR. The company offers CE IVD marked RealStar PCR kits for a variety of respiratory, enteric, blood-borne, and tropical viruses. All of the kits have been validated for use on a broad range of real-time PCR instruments. Altona also sells ExtraStar kits for DNA and RNA purification.

In April, Altona said that it had forged a four-year, €9.6 million ($12.6 million) collaboration with Germany's Bernhard Nocht Institute for Tropical Medicine to develop a specimen bank for tropical and rare diseases.

"We look forward to working closely with Malaysian talent to make this technology more accessible to healthcare practitioners here in this region," Altona founder Ulrich Spengler said in a statement. "Our collaborations with Malaysian institutions will be especially significant in global efforts as our recently announced partnership with [the] Bernhard Nocht Institute for Tropical Medicine."

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.